Aronson Solomon, Nisbet Paul, Bunke Martin
Department of Anesthesiology, Duke University, 201 Trent Drive, 101 Baker House, Durham, NC 27710 USA.
One Research, LLC, 1150 Hungryneck Blvd. Suite C-303, Mt. Pleasant, SC 29464 USA.
Perioper Med (Lond). 2017 Oct 19;6:15. doi: 10.1186/s13741-017-0071-6. eCollection 2017.
Fluid resuscitation during cardiac surgery is common with significant variability in clinical practice. Our goal was to investigate current practice patterns of fluid volume expansion in patients undergoing cardiac surgeries in the USA.
We conducted a cross-sectional online survey of 124 cardiothoracic surgeons, cardiovascular anesthesiologists, and perfusionists. Survey questions were designed to assess clinical decision-making patterns of intravenous (IV) fluid utilization in cardiovascular surgery for five types of patients who need volume expansion: (1) patients undergoing cardiopulmonary bypass (CPB) without bleeding, (2) patients undergoing CPB with bleeding, (3) patients undergoing acute normovolemic hemodilution (ANH), (4) patients requiring extracorporeal membrane oxygenation (ECMO) or use of a ventricular assist device (VAD), and (5) patients undergoing either off-pump coronary artery bypass graft (OPCABG) surgery or transcatheter aortic valve replacement (TAVR). First-choice fluid used in fluid boluses for these five patient types was requested. Descriptive statistics were performed using Kruskal-Wallis test and follow-up tests, including tests, to evaluate differences among respondent groups.
The most commonly preferred indicators of volume status were blood pressure, urine output, cardiac output, central venous pressure, and heart rate. The first choice of fluid for patients needing volume expansion during CPB without bleeding was crystalloids, whereas 5% albumin was the most preferred first choice of fluid for bleeding patients. For volume expansion during ECMO or VAD, the respondents were equally likely to prefer 5% albumin or crystalloids as a first choice of IV fluid, with 5% albumin being the most frequently used adjunct fluid to crystalloids. Surgeons, as a group, more often chose starches as an adjunct fluid to crystalloids for patients needing volume expansion during CPB without bleeding. Surgeons were also more likely to use 25% albumin as an adjunct fluid than were anesthesiologists. While most perfusionists reported using crystalloids to prime the CPB circuit, one third preferred a mixture of 25% albumin and crystalloids. Less interstitial edema and more sustained volume expansion were considered the most important colloid traits in volume expansion.
Fluid utilization practice patterns in the USA varied depending on patient characteristics and clinical specialties of health care professionals.
心脏手术期间的液体复苏很常见,临床实践中存在显著差异。我们的目标是调查美国心脏手术患者液体容量扩充的当前实践模式。
我们对124名心胸外科医生、心血管麻醉医生和灌注师进行了一项横断面在线调查。调查问题旨在评估心血管手术中静脉输液(IV)用于五种需要容量扩充的患者类型的临床决策模式:(1)接受体外循环(CPB)且无出血的患者,(2)接受CPB且有出血的患者,(3)接受急性等容血液稀释(ANH)的患者,(4)需要体外膜肺氧合(ECMO)或使用心室辅助装置(VAD)的患者,以及(5)接受非体外循环冠状动脉搭桥术(OPCABG)手术或经导管主动脉瓣置换术(TAVR)的患者。要求提供这五种患者类型在液体推注中使用的首选液体。使用Kruskal-Wallis检验和后续检验(包括检验)进行描述性统计,以评估应答组之间的差异。
最常用的容量状态指标是血压、尿量、心输出量、中心静脉压和心率。在接受CPB且无出血的情况下需要容量扩充的患者,首选液体是晶体液,而对于出血患者,5%白蛋白是最首选的液体。对于ECMO或VAD期间的容量扩充,受访者同样有可能首选5%白蛋白或晶体液作为IV液体,5%白蛋白是晶体液最常用的辅助液体。作为一个群体,外科医生在接受CPB且无出血的情况下需要容量扩充的患者中,更常选择淀粉类作为晶体液的辅助液体。外科医生也比麻醉医生更有可能使用25%白蛋白作为辅助液体。虽然大多数灌注师报告使用晶体液预充CPB回路,但三分之一的人更喜欢25%白蛋白和晶体液的混合物。较少的间质水肿和更持久的容量扩充被认为是容量扩充中最重要的胶体特性。
美国的液体使用实践模式因患者特征和医疗保健专业人员的临床专业而异。